Drug Addiction: Clinical Trials

3 trials for Drug Addiction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Drug Addiction: new trials by email Literature Review of Drug Addiction trials Research Report on Drug Addiction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
Creatine monohydrate - Depression, Dual Diagnosis
Phase 4CompletedPerry Renshaw652014-09-012025-04-08
Buprenorphine and Integrated HIV Care
Physician Management, Counseling - Substance-related Disorders, Drug Addiction
Phase 4CompletedYale University522005-09-012020-04-03
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Services will be provided at one site, Services remain dispersed; i.e., not centralized to one-location or provider. - Buprenorphine, HIV
Phase 4CompletedYale University602005-08-012015-07-24

Narrower conditions

Substance-Related Disorders (3)  ·  Opioid-Related Disorders (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Depression (1)  ·  HIV Infections (1)

Broader conditions

Chemically-Induced Disorders (3)  ·  Mental Disorders (3)  ·  Narcotic-Related Disorders (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)

Interventions

Counseling (1)  ·  Creatine (1)  ·  Practice Management (1)

Sponsors

Yale University (2)  ·  Perry Renshaw (1)

Countries

United States (3)

Top investigators

Christopher J Cutter, Ph.D. (1)  ·  Frederick Altice, MD (1)  ·  Perry Renshaw, MD, PhD, MBA (1)